TuHURA BIOSCIENCES, INC./NV Cash and Restricted Cash
TuHURA BIOSCIENCES, INC./NV (HURA) had Cash and Restricted Cash of $995.98 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $995.98K.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6.30M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $3.62M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $2.70M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents as first filed |
|---|---|---|
| 2026-06-30 | $995.98K 10-Q · filed 2026-08-14 | |
| 2026-03-31 | $6.30M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $3.62M 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $2.70M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $8.51M 10-Q · filed 2026-08-14 | |
| 2025-03-31 | $6.22M 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $12.66M 10-Q · filed 2026-08-14 | |
| 2024-09-30 | $19.60M 10-Q · filed 2025-11-14 | $3.02M 10-Q · filed 2024-11-14 |
| 2024-06-30 | $12.31M 10-Q · filed 2025-08-14 | $4.91M 10-K · filed 2024-10-07 |
| 2024-03-31 | $4.46M 10-Q · filed 2025-05-15 | $6.35M 10-Q · filed 2024-05-14 |
| 2023-12-31 | $3.67M 10-K · filed 2026-03-31 | $658.00K 10-Q · filed 2024-02-14 |
| 2023-09-30 | $216.00K 10-Q · filed 2024-11-14 | |
| 2023-06-30 | $1.53M 10-Q · filed 2024-11-14 | |
| 2023-03-31 | $3.04M 10-Q · filed 2024-05-14 | |
| 2022-12-31 | $14.25M 10-K · filed 2025-03-31 | $4.87M 10-Q · filed 2023-02-14 |
| 2022-09-30 | $7.08M 10-Q · filed 2023-11-13 | |
| 2022-06-30 | $11.78M 10-K · filed 2024-10-07 | |
| 2022-03-31 | $8.84M 10-Q · filed 2023-05-11 | |
| 2021-12-31 | $14.06M 10-Q · filed 2023-02-14 | |
| 2021-09-30 | $19.34M 10-Q · filed 2022-11-09 | |
| 2021-06-30 | $10.54M 10-K · filed 2023-09-18 | |
| 2021-03-31 | $15.72M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | $17.16M 10-Q · filed 2022-02-11 | |
| 2020-09-30 | $22.60M 10-Q · filed 2021-11-15 | |
| 2020-06-30 | $2.39M 10-K · filed 2022-09-27 | $2.39M 10-K · filed 2020-09-18 |
| 2020-03-31 | $4.97M 10-Q · filed 2021-05-13 | |
| 2019-12-31 | $6.35M 10-Q · filed 2021-02-12 | |
| 2019-09-30 | $8.06M 10-Q · filed 2020-11-12 | |
| 2019-06-30 | $3.72M 10-K · filed 2021-09-28 | $3.72M 10-K · filed 2020-09-18 |
| 2018-06-30 | $5.97M 10-K · filed 2020-09-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |